secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ayala Pharmaceuticals, Inc. (—)
CIK:        0001100397
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0000929638-24-000901
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ayala Pharmaceuticals issues $2M convertible notes and warrants to existing lenders
--------------------------------------------------------------------------------

- Issued $2M in Senior Convertible Promissory Notes due Nov 2028 to existing noteholders on March 1, 2024.
- Warrants to purchase 7.5M shares of common stock issued alongside notes, exercisable at 50% of market price.
- Notes carry interest at SOFR + 7%, convertible at 50% of market price, subject to mandatory conversion.
- Drawdown pursuant to November 2023 Side Letter Agreement; remaining $2M available until May 17, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100397/000092963824000901/0000929638-24-000901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100397/000092963824000901/a8k.htm
  HTML page:      https://secwatch.observer/filing/0000929638-24-000901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer